Past Events

Experience BIO-Europe and connect with delegates spanning the global life science ecosystem to propel dealmaking and innovation

This conference is dedicated to the discussion of advances in the field of Drug and Nucleic Acid Delivery for Biomedical Research and Applications. The event will host leading researchers working in the field and will offer multiple opportunities for networking. By organizing this event, we aim to foster the initiation of collaborative projects between the meeting participants on drug formulation and delivery for diverse therapeutic applications.

Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 120+ dedicated presentations by the leading publicly traded and privately held companies in the space.

Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

The world’s best and brightest in stem cell research and regenerative medicine convene once a year for the ISSCR Annual Meeting, and you are invited! Join more than 4,000 scientists from around the globe at ISSCR 2024 to take part in a 4-day program comprising the year’s most significant new advances in the field.

Meet us at booth #4023

ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.

Over the years we have fostered strong relationships with local partners such as the Canton of Basel, Novartis, Roche and various incubators to cover the full pipeline of drug development. The congress features senior speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems and academic groups creating endless networking opportunities.